Long-term effects on growth, development, and metabolism of ALL treatment in childhood

References

• Edelstein K, D’Agostino S, Bernstein LJ, et al. Long-term neurocognitive outcomes in young adult survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2011 Aug;33(6):450–458.
   PubMed Web of Science ®Google Scholar
• Redaelli A, Laskin BL, Stephens JM, et al. A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL). Eur J Cancer Care (Engl). 2005 Mar;14(1):53–62.
   PubMed Web of Science ®Google Scholar
• Ness KK, Armenian SH, Kadan-Lottick N, et al. Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health. Expert Rev Hematol. 2011 Apr 4;(2): 185–197. DOI:10.1586/ehm.11.8.
   PubMed Web of Science ®Google Scholar
• Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008 Mar 22;371(9617):1030–1043.
   PubMed Web of Science ®Google Scholar
• Nathan PC, Wasilewski-Masker K, Janzen LA. Long-term outcomes in survivors of childhood acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009 Oct;23(5):1065–82, vi-vii.
   PubMed Web of Science ®Google Scholar
• Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013 Jun 1;381(9881):1943–1955.
   PubMed Web of Science ®Google Scholar
• Jeha S, Pui CH. Risk-adapted treatment of pediatric acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009 Oct;23(5):973–990.
   PubMed Web of Science ®Google Scholar
• Schriock EA, Schell MJ, Carter M, et al. Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia. J Clin Oncol. 1991 Mar;9(3):400–405.
   PubMed Web of Science ®Google Scholar
• Vilela MI, Viana MB. Longitudinal growth and risk factors for growth deficiency in children treated for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2007 Jan;48(1):86–92.
   PubMed Web of Science ®Google Scholar
• Ben Arush MW, Elhasid R. Effects of radiotherapy on the growth of children with leukemia. Pediatr Endocrinol Rev. 2008 Mar;5(3):785–788.
   PubMedGoogle Scholar
• Uruena M, Stanhope R, Chessells JM, et al. Impaired pubertal growth in acute lymphoblastic leukaemia. Arch Dis Child. 1991 Dec;66(12):1403–1407.
   PubMed Web of Science ®Google Scholar
• Withycombe JS, Post-White JE, Meza JL, et al. Weight patterns in children with higher risk ALL: a report from the Children’s Oncology Group (COG) for CCG 1961. Pediatr Blood Cancer. 2009 Dec 15;53(7):1249–1254.
   PubMed Web of Science ®Google Scholar
• Shalet SM, Clayton PE, Morris-Jones PH, et al. Growth in children treated for acute lymphoblastic leukaemia. Lancet. 1988 Jul 16;2(8603):164.
   PubMed Web of Science ®Google Scholar
• Davies HA, Didcock E, Didi M, et al. Disproportionate short stature after cranial irradiation and combination chemotherapy for leukaemia. Arch Dis Child. 1994 Jun;70(6):472–475.
   PubMed Web of Science ®Google Scholar
• Sklar C, Mertens A, Walter A, et al. Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation. J Pediatr. 1993 Jul;123(1):59–64.
   PubMed Web of Science ®Google Scholar
• Hokken-Koelega AC, van Doorn JW, Hählen K, et al. Long-term effects of treatment for acute lymphoblastic leukemia with and without cranial irradiation on growth and puberty: a comparative study. Pediatr Res. 1993 Jun;33(6):577–582.
   PubMed Web of Science ®Google Scholar
• Katz JA, Pollock BH, Jacaruso D, et al. Final attained height in patients successfully treated for childhood acute lymphoblastic leukemia. J Pediatr. 1993 Oct;123(4):546–552.
   PubMed Web of Science ®Google Scholar
• Holm K, Nysom K, Hertz H, et al. Normal final height after treatment for acute lymphoblastic leukemia without irradiation. Acta Paediatr. 1994 Dec;83(12):1287–1290.
   PubMed Web of Science ®Google Scholar
• Birkebaek NH, Fisker S, Clausen N, et al. Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol. 1998 Jun;30(6):351–356.
   PubMedGoogle Scholar
• Bongers ME, Francken AB, Rouwé C, et al. Reduction of adult height in childhood acute lymphoblastic leukemia survivors after prophylactic cranial irradiation. Pediatr Blood Cancer. 2005 Aug;45(2):139–143.
   PubMed Web of Science ®Google Scholar
• Breene RA, Williams RM, Hartle J, et al. Auxological changes in UK survivors of childhood acute lymphoblastic leukaemia treated without cranial irradiation. Br J Cancer. 2011 Mar;104(5):746–749.
   PubMed Web of Science ®Google Scholar
• Vandecruys E, Dhooge C, Craen M, et al. Longitudinal linear growth and final height is impaired in childhood acute lymphoblastic leukemia survivors after treatment without cranial irradiation. J Pediatr. 2013 Jul;163(1):268–273.
   PubMed Web of Science ®Google Scholar
• Bruzzi P, Predieri B, Corrias A, et al. Final height and body mass index in adult survivors of childhood acute lymphoblastic leukemia treated without cranial radiotherapy: a retrospective longitudinal multicenter Italian study. BMC Pediatr. 2014;14:236.
   PubMed Web of Science ®Google Scholar
• Chow EJ, Pihoker C, Hunt K, et al. Obesity and hypertension among children after treatment for acute lymphoblastic leukemia. Cancer. 2007 Nov 15;110(10):2313–2320.
   PubMed Web of Science ®Google Scholar
• Van der Sluis IM, van Den Heuvel-Eibrink MM, Hählen K, et al. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol. 2000 Oct;35(4):415–420.
   PubMedGoogle Scholar
• Rose SR, Schreiber RE, Kearney NS, et al. Hypothalamic dysfunction after chemotherapy. J Pediatr Endocrinol Metab. 2004 Jan;17(1):55–66.
   PubMed Web of Science ®Google Scholar
• Haddy TB, Mosher RB, Nunez SB, et al. Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation. Pediatr Blood Cancer. 2006 Feb;46(2):258–261.
   PubMed Web of Science ®Google Scholar
• Leung W, Rose SR, Zhou Y, et al. Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol. 2002 Jul 1;20(13):2959–2964.
   PubMed Web of Science ®Google Scholar
• Green DM, Williams PD, Simpson L, et al. Evaluation of the chronic hepatic toxicity of 6-mercaptopurine in the wistar rat. Oncology. 1983;40(2):138–142.
   PubMed Web of Science ®Google Scholar
• Ahmed SF, Wallace WH, Kelnar CJ. An anthropometric study of children during intensive chemotherapy for acute lymphoblastic leukaemia. Horm Res. 1997;48(4):178–183.
   PubMedGoogle Scholar
• Kirk JA, Raghupathy P, Stevens MM, et al. Growth failure and growth-hormone deficiency after treatment for acute lymphoblastic leukaemia. Lancet. 1987 Jan 24;1(8526):190–193.
   PubMed Web of Science ®Google Scholar
• Chen AC, Okcu MF, Dreyer ZE, et al. Comparison of height and weight after 12 vs. 18 Gy cranial radiation therapy in pediatric acute lymphoblastic leukemia (ALL) patients. Adv Radiat Oncol. 2017 Feb 1;2(2):228–234.
   PubMedGoogle Scholar
• Sanders JE. Growth and development after hematopoietic cell transplant in children. Bone Marrow Transplant. 2008;41:223–227.
   PubMed Web of Science ®Google Scholar
• Galletto C, Gliozzi A, Nucera D, et al. Growth impairment after TBI of leukemia survivors children: a model-based investigation. Theor Biol Med Modell. 2014;11:44.
   PubMed Web of Science ®Google Scholar
• Quigley C, Cowell C, Jimenez M, et al. Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukemia. N Engl J Med. 1989 Jul 20;321(3):143–151.
   PubMed Web of Science ®Google Scholar
• Oberfield SE, Soranno D, Nirenberg A, et al. Age at onset of puberty following high-dose central nervous system radiation therapy. Arch Pediatr Adolesc Med. 1996 Jun;150(6):589–592.
   PubMedGoogle Scholar
• Groot-Loonen JJ, van Setten P, Otten BJ, et al. Shortened and diminished pubertal growth in boys and girls treated for acute lymphoblastic leukaemia. Acta Paediatr. 1996 Sep;85(9):1091–1095.
   PubMed Web of Science ®Google Scholar
• Chow EJ, Friedman DL, Yasui Y, et al. Timing of menarche among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2008 Apr;50(4):854–858.
   PubMed Web of Science ®Google Scholar
• Leiper AD, Stanhope R, Kitching P, et al. Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia. Arch Dis Child. 1987 Nov;62(11):1107–1112.
   PubMed Web of Science ®Google Scholar
• Mills JL, Fears TR, Robison LL, et al. Menarche in a cohort of 188 long-term survivors of acute lymphoblastic leukemia. J Pediatr. 1997 Oct;131(4):598–602.
   PubMed Web of Science ®Google Scholar
• Didcock E, Davies HA, Didi M, et al. Pubertal growth in young adult survivors of childhood leukemia. J Clin Oncol. 1995 Oct;13(10):2503–2507.
   PubMed Web of Science ®Google Scholar
• Pizzo AP, Poplack DG. Principles and practice of pediatric oncology. 5th ed ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 538–590.
   Google Scholar
• Sklar C. Growth and endocrine disturbances after bone marrow transplantation in childhood. Acta Paediatr Suppl. 1995 Sep;411:57–61.
   PubMedGoogle Scholar
• Chemaitilly W, Mertens AC, Mitby P, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab. 2006 May;91(5):1723–1728.
   PubMed Web of Science ®Google Scholar
• Sklar CA, Robison LL, Nesbit ME, et al. Effects of radiation on testicular function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Children Cancer Study Group. J Clin Oncol. 1990 Dec;8(12):1981–1987.
   PubMed Web of Science ®Google Scholar
• Sarafoglou K, Boulad F, Gillio A, et al. Gonadal function after bone marrow transplantation for acute leukemia during childhood. J Pediatr. 1997 Feb;130(2):210–216.
   PubMed Web of Science ®Google Scholar
• Shalet SM, Tsatsoulis A, Whitehead E, et al. Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J Endocrinol. 1989 Jan;120(1):161–165.
   PubMed Web of Science ®Google Scholar
• Blatt J, Poplack DG, Sherins RJ. Testicular function in boys after chemotherapy for acute lymphoblastic leukemia. N Engl J Med. 1981 May 7;304(19):1121–1124.
   PubMed Web of Science ®Google Scholar
• Sklar CA. Growth and pubertal development in survivors of childhood cancer. Pediatrician. 1991;18(1):53–60.
   PubMedGoogle Scholar
• Rappaport R, Brauner R, Czernichow P, et al. Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors. J Clin Endocrinol Metab. 1982 Jun;54(6):1164–1168.
   PubMed Web of Science ®Google Scholar
• Green DM, Zhu L, Wang M, et al. Effect of cranial irradiation on sperm concentration of adult survivors of childhood acute lymphoblastic leukemia: a report from the St. Jude Lifetime Cohort Study. Hum Reprod. 2017 Jun 1;32(6):1192–1201.
   PubMed Web of Science ®Google Scholar
• Chow EJ, Stratton KL, Leisenring WM, et al. Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2016 May;17(5):567–576.
   PubMed Web of Science ®Google Scholar
• Brydøy M, Fosså SD, Dahl O, et al. Gonadal dysfunction and fertility problems in cancer survivors. Acta Oncol. 2007;46(4):480–489.
   PubMed Web of Science ®Google Scholar
• Blatt J, Sherins RJ, Niebrugge D, et al. Leydig cell function in boys following treatment for testicular relapse of acute lymphoblastic leukemia. J Clin Oncol. 1985;3(9):1227.
   PubMed Web of Science ®Google Scholar
• Jahnukainen K, Heikkinen R, Henriksson M, et al. Semen quality and fertility in adult long-term survivors of childhood acute lymphoblastic leukemia. Fertil Steril. 2011 Oct;96(4):837–842.
   PubMed Web of Science ®Google Scholar
• Žulpaitė R1, Bumbulienė Ž. Reproductive health of female childhood cancer survivors. Ginekol Pol. 2018;89(5):280–286.
   PubMed Web of Science ®Google Scholar
• van der Kooi ALF, van Den Heuvel-Eibrink MM, van Noortwijk A, et al. Longitudinal follow-up in female childhood cancer survivors: no signs of accelerated ovarian function loss. Hum Reprod. 2017;32(1):193–200.
   PubMed Web of Science ®Google Scholar
• Dolmans MM, Marinescu C, Saussoy P, et al. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010 Oct 21;116(16):2908–2914.
   PubMed Web of Science ®Google Scholar
• Elgindy E, Sibai H, Abdelghani A, et al. Protecting ovaries during chemotherapy through gonad suppression: a systematic review and meta-analysis. Obstet Gynecol. 2015 Jul;126(1):187–195.
   PubMed Web of Science ®Google Scholar
• Armstrong GT, Kawashima T, Leisenring W, et al. Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol. 2014 Apr 20;32(12):1218–1227.
   PubMed Web of Science ®Google Scholar
• Kavey RE, Allada V, Daniels SR, et al. American Heart Association Expert Panel on Population and Prevention Science; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Nutrition, Physical Activity and Metabolism; American Heart Association Council on High Blood Pressure Research; American Heart Association Council on Cardiovascular Nursing; American Heart Association Council on the Kidney in Heart Disease; Interdisciplinary Working Group on Quality of Care and Outcomes Research. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; The councils on cardiovascular disease in the young, epidemiology and prevention, nutrition, physical activity and metabolism, high blood pressure research, cardiovascular nursing, and the kidney in heart disease; and the interdisciplinary working group on quality of care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2006 Dec 12;114(24):2710–2738.
   PubMed Web of Science ®Google Scholar
• Armstrong GT, Oeffinger KC, Chen Y, et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013 Oct 10;31(29):3673–3680.
   PubMed Web of Science ®Google Scholar
• Smith WA, Li C, Nottage KA, et al. Lifestyle and metabolic syndrome in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study. Cancer. 2014 Sep 1;120(17):2742–2750.
   PubMed Web of Science ®Google Scholar
• Zhang FF, Liu S, Chung M, et al. Growth patterns during and after treatment in patients with pediatric ALL: a meta-analysis. Pediatr Blood Cancer. 2015 Aug; 62(8):1452–1460.
   PubMed Web of Science ®Google Scholar
• Brouwer CA, Gietema JA, Kamps WA, et al. Changes in body composition after childhood cancer treatment: impact on future health status–a review. Crit Rev Oncol Hematol. 2007 Jul;63(1):32–46.
   PubMed Web of Science ®Google Scholar
• Zhang FF, Rodday AM, Kelly MJ, et al. Predictors of being overweight or obese in survivors of pediatric acute lymphoblastic leukemia (ALL). Pediatr Blood Cancer. 2014 Jul;61(7):1263–1269.
   PubMed Web of Science ®Google Scholar
• Withycombe JS, Smith LM, Meza JL, et al. Weight change during childhood acute lymphoblastic leukemia induction therapy predicts obesity: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2015 Mar;62(3):434–439.
   PubMed Web of Science ®Google Scholar
• Didi M, Didcock E, Davies HA, et al. High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood. J Pediatr. 1995 Jul;127(1):63–67.
   PubMed Web of Science ®Google Scholar
• Rogers PC, Meacham LR, Oeffinger KC, et al. Obesity in pediatric oncology. Pediatr Blood Cancer. 2005 Dec;45(7):881–891.
   PubMed Web of Science ®Google Scholar
• Fuemmeler BF, Pendzich MK, Clark K, et al. Diet, physical activity, and body composition changes during the first year of treatment for childhood acute leukemia and lymphoma. J Pediatr Hematol Oncol. 2013 Aug;35(6):437–443.
   PubMed Web of Science ®Google Scholar
• Jenney ME, Faragher EB, Jones PH, et al. Lung function and exercise capacity in survivors of childhood leukaemia. Med Pediatr Oncol. 1995 Apr;24(4):222–230.
   PubMedGoogle Scholar
• Oeffinger KC, Mertens AC, Sklar CA, et al. Childhood Cancer Survivor Study. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2003 Apr 1;21(7):1359–1365.
   PubMed Web of Science ®Google Scholar
• Adan L, Trivin C, Sainte-Rose C, et al. GH deficiency caused by cranial irradiation during childhood: factors and markers in young adults. J Clin Endocrinol Metab. 2001 Nov;86(11):5245–5251.
   PubMed Web of Science ®Google Scholar
• Cicognani A, Cacciari E, Rosito P, et al. Longitudinal growth and final height in long-term survivors of childhood leukaemia. Eur J Pediatr. 1994 Oct;153(10):726–730.
   PubMed Web of Science ®Google Scholar
• Lindemulder SJ, Stork LC, Bostrom B, et al. Survivors of standard risk acute lymphoblastic leukemia do not have increased risk for overweight and obesity compared to non-cancer peers: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2015 Jun;62(6):1035–1041.
   PubMed Web of Science ®Google Scholar
• Vaisman N, Stallings VA, Chan H, et al. Effect of chemotherapy on the energy and protein metabolism of children near the end of treatment for acute lymphoblastic leukemia. Am J Clin Nutr. 1993 May;57(5):679–684.
   PubMed Web of Science ®Google Scholar
• Razzouk BI, Rose SR, Hongeng S, et al. Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma. J Clin Oncol. 2007 Apr 1;25(10):1183–1189.
   PubMed Web of Science ®Google Scholar
• Siviero-Miachon AA, Spinola-Castro AM, Guerra-Junior G. Adiposity in childhood cancer survivors: insights into obesity physiopathology. Arq Bras Endocrinol Metabol. 2009 Mar;53(2):190–200.
   PubMedGoogle Scholar
• Jarfelt M, Lannering B, Bosaeus I, et al. Body composition in young adult survivors of childhood acute lymphoblastic leukaemia. Eur J Endocrinol. 2005 Jul;153(1):81–89.
   PubMed Web of Science ®Google Scholar
• Gurney JG, Ness KK, Sibley SD, et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. Cancer. 2006 Sep 15;107(6):1303–1312.
   PubMed Web of Science ®Google Scholar
• Màrky I, Mellander L, Lannering B, et al. A longitudinal study of growth and growth hormone secretion in children during treatment for acute lymphoblastic leukemia. Med Pediatr Oncol. 1991;19(4):258–264.
   PubMedGoogle Scholar
• Davies JH, Evans BA, Jones E, et al. Osteopenia, excess adiposity and hyperleptinaemia during 2 years of treatment for childhood acute lymphoblastic leukaemia without cranial irradiation. Clin Endocrinol (Oxf). 2004 Mar;60(3):358–365.
   PubMed Web of Science ®Google Scholar
• Bostrom BC, Sensel MR, Sather HN, et al. Children’s Cancer Group. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children’s Cancer Group. Blood. 2003 May 15;101(10):3809–3817.
   PubMed Web of Science ®Google Scholar
• Warris LT, van Den Heuvel-Eibrink MM, Den Hoed MA, et al. Does dexamethasone induce more neuropsychological side effects than prednisone in pediatric acute lymphoblastic leukemia? A systematic review. Pediatr Blood Cancer. 2014 Jul;61(7):1313–1318.
   PubMed Web of Science ®Google Scholar
• Touyz LM, Cohen J, Neville KA, et al. Changes in body mass index in long-term survivors of childhood acute lymphoblastic leukemia treated without cranial radiation and with reduced glucocorticoid therapy. Pediatr Blood Cancer. 2017;64:e26344.
   Google Scholar
• Rolland-Cachera MF, Deheeger M, Bellisle F, et al. Adiposity rebound in children: a simple indicator for predicting obesity. Am J Clin Nutr. 1984 Jan;39(1):129–135.
   PubMed Web of Science ®Google Scholar
• Williams SM, Goulding A. Patterns of growth associated with the timing of adiposity rebound. Obesity. 2009 Feb;17(2):335–341. (Silver Spring)
   PubMed Web of Science ®Google Scholar
• Reilly JJ, Kelly A, Ness P, et al. ALSPAC Study Team. Premature adiposity rebound in children treated for acute lymphoblastic leukemia. J Clin Endocrinol Metab. 2001 Jun;86(6):2775–2778.
   PubMed Web of Science ®Google Scholar
• Zareifar S, Shorafa S, Haghpanah S, et al. Association of serum leptin level with obesity in children with acute lymphoblastic leukemia. Iran J Ped Hematol Oncol. 2015;5(3):116–124.
   PubMed Web of Science ®Google Scholar
• Wallace AM, Tucker P, Williams DM, et al. Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia. Clin Endocrinol (Oxf). 2003 Jun;58(6):770–776.
   PubMed Web of Science ®Google Scholar
• Ross JA, Oeffinger KC, Davies SM, et al. Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2004 Sep 1;22(17):3558–3562.
   PubMed Web of Science ®Google Scholar
• Garmey EG, Liu Q, Sklar CA, et al. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2008 Oct 1;26(28):4639–4645.
   PubMed Web of Science ®Google Scholar
• Shaw MP, Bath LE, Duff J, et al. Obesity in leukemia survivors: the familial contribution. Pediatr Hematol Oncol. 2000 Apr-May;17(3):231–237.
   PubMed Web of Science ®Google Scholar
• Nottage KA, Ness KK, Li C, et al. Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia – from the St. Jude Lifetime Cohort. Br J Haematol. 2014 May;165(3):364–374.
   PubMed Web of Science ®Google Scholar
• Talvensaari KK, Lanning M, Tapanainen P, et al. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab. 1996 Aug;81(8):3051–3055.
   PubMed Web of Science ®Google Scholar
• Kourti M, Tragiannidis A, Makedou A, et al. Metabolic syndrome in children and adolescents with acute lymphoblastic leukemia after the completion of chemotherapy. J Pediatr Hematol Oncol. 2005 Sep;27(9):499–501.
   PubMed Web of Science ®Google Scholar
• Trimis G, Moschovi M, Papassotiriou I, et al. Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease. J Pediatr Hematol Oncol. 2007 May;29(5):309–314.
   PubMed Web of Science ®Google Scholar
• Van Waas M, Neggers SJ, van der Lelij AJ, et al. The metabolic syndrome in adult survivors of childhood cancer, a review. J Pediatr Hematol Oncol. 2010 Apr;32(3):171–179.
   PubMed Web of Science ®Google Scholar
• Oudin C, Simeoni MC, Sirvent N, et al. Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia. Blood. 2011 Apr 28;117(17):4442–4448.
   PubMed Web of Science ®Google Scholar
• Gunn HM, Emilsson H, Gabriel M, et al. Metabolic health in childhood cancer survivors: a longitudinal study in a long-term follow-up clinic. J Adolesc Young Adult Oncol. 2016 Mar;5(1):24–30.
   PubMed Web of Science ®Google Scholar
• Gibson TM, Ehrhardt MJ, Ness KK. Obesity and metabolic syndrome among adult survivors of childhood leukemia.curr. Treat Options Oncol. 2016 Apr;17(4):17.
   PubMed Web of Science ®Google Scholar
• Kojima C, Kubota M, Nagai A, et al. Adipocytokines in childhood cancer survivors and correlation with metabolic syndrome components. Pediatr Int. 2013 Aug;55(4):438–442.
   PubMed Web of Science ®Google Scholar
• Mohn A, Chiarelli F, Di Marzio A, et al. Thyroid function in children treated for acute lymphoblastic leukemia. J Endocrinol Invest. 1997 Apr;20(4):215–219.
   PubMed Web of Science ®Google Scholar
• Chow EJ, Friedman DL, Stovall M, et al. Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2009 Sep;53(3):432–437.
   PubMed Web of Science ®Google Scholar
• Mooij CF, van Alfen-van der Velden JAEM, Netea-Maier RT, et al. Pancytopenia and hypothyroidism in a patient with leukemic infiltration of the thyroid as the first presentation of acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2017 May 29. DOI:10.1097/MPH.0000000000000869.
   Web of Science ®Google Scholar
• Fulbright JM, Raman S, McClellan WS, et al. Late effects of childhood leukemia therapy. Curr Hematol Malig Rep. 2011 Sep;6(3):195–205.
   PubMed Web of Science ®Google Scholar
• Sanders JE, Hoffmeister PA, Woolfrey AE, et al. Thyroid function following hematopoietic cell transplantation in children: 30 years’ experience. Blood. 2009;113(2):306–8).
   PubMed Web of Science ®Google Scholar
• Late effects of treatment for childhood cancer (PDQ®). NCBI Bookshelf. Available from: https://www.ncbi.nlm.nih.gov/books/NBK65832/?report=printable
   Google Scholar
• Delvecchio M, Cecinati V, Brescia LP, et al. Thyroid function and thyroid autoimmunity in childhood acute lymphoblastic leukemia off-therapy patients treated only with chemotherapy. J Endocrinol Invest. 2010 Mar;33(3):135–139.
   PubMed Web of Science ®Google Scholar
• Baronio F, Battisti L, Radetti G. Central hypothyroidism following chemotherapy for acute lymphoblastic leukemia. J Pediatr Endocrinol Metab. 2011;24(11–12):903–906.
   PubMed Web of Science ®Google Scholar
• Lando A, Holm K, Nysom K, et al. Thyroid function in survivors of childhood acute lymphoblastic leukaemia: the significance of prophylactic cranial irradiation. Clin Endocrinol (Oxf). 2001 Jul;55(1):21–25.
   PubMed Web of Science ®Google Scholar
• Bhatti P, Veiga LH, Ronckers CM, et al. Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res. 2010 Dec;174(6):741–752.
   PubMed Web of Science ®Google Scholar
• Leonard MB, Elmi A, Mostoufi-Moab S, et al. Effects of sex, race, and puberty on cortical bone and the functional muscle bone unit in children, adolescents, and young adults. J Clin Endocrinol Metab. 2010 Apr;95(4):1681–1689.
   PubMed Web of Science ®Google Scholar
• Willson JK. The bone lesions of childhood leukemia; a survey of 140 cases. Radiology. 1959 May;72(5):672–681.
   PubMed Web of Science ®Google Scholar
• Mostoufi-Moab S, Halton J. Bone morbidity in childhood leukemia: epidemiology, mechanisms, diagnosis, and treatment. Curr Osteoporos Rep. 2014 Sep;12(3):300–312.
   PubMed Web of Science ®Google Scholar
• Riccio I, Marcarelli M, Del Regno N, et al. Musculoskeletal problems in pediatric acute leukemia. J Pediatr Orthop B. 2013 May;22(3):264–269.
   PubMed Web of Science ®Google Scholar
• Halton J, Gaboury I, Grant R, et al. Canadian STOPP Consortium. Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program. J Bone Miner Res. 2009 Jul;24(7):1326–1334.
   PubMed Web of Science ®Google Scholar
• Arikoski P, Komulainen J, Riikonen P, et al. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study. J Clin Endocrinol Metab. 1999 Sep;84(9):3174–3181.
   PubMed Web of Science ®Google Scholar
• van der Sluis IM, van Den Heuvel-Eibrink MM, Hählen K, et al. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr. 2002 Aug;141(2):204–210.
   PubMed Web of Science ®Google Scholar
• Alos N, Grant RM, Ramsay T, et al. High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy. J Clin Oncol. 2012 Aug 1;30(22):2760–2767.
   PubMed Web of Science ®Google Scholar
• Arikoski P, Komulainen J, Riikonen P, et al. Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer. J Bone Miner Res. 1999 Dec;14(12):2002–2009.
   PubMed Web of Science ®Google Scholar
• Siebler T, Shalet SM, Robson H. Effects of chemotherapy on bone metabolism and skeletal growth. Horm Res. 2002;58(Suppl. 1):80–85. 64769.
   PubMedGoogle Scholar
• te Winkel ML, Pieters R, Hop WC, et al. Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol. Bone. 2014 Feb;59:223–228.
   PubMed Web of Science ®Google Scholar
• Davies JH, Evans BA, Jenney ME, et al. Effects of chemotherapeutic agents on the function of primary human osteoblast-like cells derived from children. J Clin Endocrinol Metab. 2003 Dec;88(12):6088–6097.
   PubMed Web of Science ®Google Scholar
• Mäkitie O, Heikkinen R, Toiviainen-Salo S, et al. Long-term skeletal consequences of childhood acute lymphoblastic leukemia in adult males: a cohort study. Eur J Endocrinol. 2013 Jan 17;168(2):281–288.
   PubMed Web of Science ®Google Scholar
• Marinovic D, Dorgeret S, Lescoeur B, et al. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study. Pediatrics. 2005 Jul;116(1):e102–8.
   PubMed Web of Science ®Google Scholar
• Kaste SC, Rai SN, Fleming K, et al. Changes in bone mineral density in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2006 Jan;46(1):77–87.
   PubMed Web of Science ®Google Scholar
• Gunes AM, Can E, Saglam H, et al. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2010 Apr;32(3):e102–7.
   PubMed Web of Science ®Google Scholar
• Rohani F, Arjmandi Rafsanjani K, Bahoush G, et al. Bone mineral density in survivors of childhood acute lymphoblastic leukemia. Asian Pac J Cancer Prev. 2017 Feb 1;18(2):535–540.
   PubMedGoogle Scholar
• Kadan-Lottick N, Marshall JA, Barón AE, et al. Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998. J Pediatr. 2001 Jun;138(6):898–904.
   PubMed Web of Science ®Google Scholar
• Tillmann V, Darlington AS, Eiser C, et al. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia. J Bone Miner Res. 2002 Jun;17(6):1073–1080.
   PubMed Web of Science ®Google Scholar
• Brennan BM, Mughal Z, Roberts SA, et al. Bone mineral density in childhood survivors of acute lymphoblastic leukemia treated without cranial irradiation. J Clin Endocrinol Metab. 2005 Feb;90(2):689–694.
   PubMed Web of Science ®Google Scholar
• Jain S, Kapoor G, Virmani A, et al. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2017 Apr;64(4). DOI:10.1002/pbc.26271
   PubMed Web of Science ®Google Scholar
• Gurney JG, Kaste SC, Liu W, et al. Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer. 2014 Jul;61(7):1270–1276.
   PubMed Web of Science ®Google Scholar
• Mostoufi-Moab S, Ginsberg JP, Bunin N, et al. Bone density and structure in long-term survivors of pediatric allogeneic hematopoietic stem cell transplantation. J Bone Miner Res. 2012 Apr;27(4):760–769.
   PubMed Web of Science ®Google Scholar
• Kawedia JD, Kaste SC, Pei D, et al. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood. 2011 Feb 24;117(8):2340–2347. quiz 2556.
   PubMed Web of Science ®Google Scholar
• Karimova EJ, Rai SN, Howard SC, et al. Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphoma. J Clin Oncol. 2007 Apr 20;25(12):1525–1531.
   PubMed Web of Science ®Google Scholar
• Elmantaser M, Stewart G, Young D, et al. Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia. Arch Dis Child. 2010 Oct;95(10):805–809.
   PubMed Web of Science ®Google Scholar
• Padhye B, Dalla-Pozza L, Little D, et al. Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL). Cancer Med. 2016 5;May(5):960–967.
   Google Scholar
• Liu C, Kawedia JD, Cheng C, et al. Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia. Leukemia. 2012 Nov;26(11):2303–2309.
   PubMed Web of Science ®Google Scholar
• Gong LL, Fang LH, Wang HY, et al. Genetic risk factors for glucocorticoid-induced osteonecrosis: a meta-analysis. Steroids. 2013 Apr;78(4):401–408.
   PubMed Web of Science ®Google Scholar
• Parasole R, Valsecchi MG, Silvestri D, et al. Correspondence: osteonecrosis in childhood acute lymphoblastic leukemia: a retrospective cohort of the Italian association of pediatric haemato-oncology (AIEOP). Blood Cancer J. 2018;8:115.
   PubMed Web of Science ®Google Scholar
• Hudspeth VR, Gold SH, Clemmons DR. Diagnosis and monitoring endocrine dysfunction, diabetes, and obesity in a cohort of adult survivors of childhood cancer. Endocr Pract. 2017 Dec;23(12):1394–1401.
   PubMed Web of Science ®Google Scholar
• Krzyzanowska-Mittermayer K, Mattsson AF, Maiter D, et al. New neoplasm during GH replacement in adults with pituitary deficiency following malignancy: a KIMS analysis. J Clin Endocrinol Metab. 2018 Feb 1;103(2):523–531.
   PubMed Web of Science ®Google Scholar
• Brignardello E, Felicetti F, Castiglione A, et al. GH replacement therapy and second neoplasms in adult survivors of childhood cancer: a retrospective study from a single institution. J Endocrinol Invest. 2015 Feb;38(2):171–176.
   PubMed Web of Science ®Google Scholar
• Pierro J, Hogan LE, Bhatla T, et al. New targeted therapies for relapsed pediatric acute lymphoblastic leukemia. Expert Rev Anticancer Ther. 2017;17(8):725–736.
   PubMed Web of Science ®Google Scholar
• Children’s Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers, version 4.0. Monrovia, CA: Children’s Oncology Group; October 2013; Available on-line: www.survivorshipguidelines.org
   Google Scholar